Cassipourol and β-sitosterol from Malva parviflora L.: a mechanistic study of dual anti-inflammatory action against COX/LOX and TNF-α/BCL-2

Abstract Although inflammation protects our bodies against harmful stimuli, uncontrolled inflammation drives serious chronic disorders. Malva parviflora L. (family Malvaceae) may represent a source for anti-inflammatory metabolites based on its potent anti-inflammatory activity. Its total ethanol extract demonstrated notable inhibition of cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX), with IC 50 values comparable to those of the reference drugs indomethacin and zileuton, respectively. The hexane fraction was the most active fraction (lowest IC₅₀) among the solvent partitions (dichloromethane, ethyl acetate, and butanol). Subsequent column chromatography of the hexane fraction produced two compounds: Cassipourol, isolated for the first time from the Malvaceae family, and β -sitosterol. Their structures were confirmed by matching their NMR and mass spectrometry data with literature. Both were validated in vitro as dual COX/LOX inhibitors, exhibiting IC₅₀ values comparable to those of the standards. To uncover additional mechanisms, a compound–target–inflammation network was constructed using network pharmacology approaches, revealing 178 shared targets. Among these, tumor necrosis factor (TNF- α ) and the antiapoptotic protein B-cell lymphoma 2 (BCL-2) emerged as central nodes linked to inflammatory pathways. Subsequent assays in human colon carcinoma (Caco-2) and lung adenocarcinoma (A549) cell lines showed that β -sitosterol suppressed TNF- α and BCL-2 by approximately 55%, whereas cassipourol displayed only modest inhibition (~20%). Molecular docking predicted moderate ( ca. –4.5) and strong (> –5) binding affinities of both compounds to key inflammatory targets. Collectively, these results suggest that β -sitosterol from M. parviflora is a promising multitarget lead for inflammatory disorders, including cancer, whereas cassipourol requires further structural optimization and mechanistic investigation to improve its unfavorable physicochemical properties.

Authors

Publication Details

Journal
Scientific Reports
Published
2026-06-13
DOI
https://doi.org/10.1038/s41598-026-56631-1
Primary Topic
Cholesterol and Lipid Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cassipourol and β-sitosterol from Malva parviflora L.: a mechanistic study of dual anti-inflammatory action against COX/LOX and TNF-α/BCL-2

Rania A. El Gedaily, Shymaa I. A. Abdel-dayem, Mohamed Anwar, Ahmed Elshewy et al.
Scientific Reports
Cholesterol and Lipid Metabolism
article

Cassipourol and β-sitosterol from Malva parviflora L.: a mechanistic study of dual anti-inflammatory action against COX/LOX and TNF-α/BCL-2

Rania A. El Gedaily, Shymaa I. A. Abdel-dayem, Mohamed Anwar, Ahmed Elshewy, Zeinab A. Kandil, Wael M. Aboulthana
article en

Abstract

Abstract Although inflammation protects our bodies against harmful stimuli, uncontrolled inflammation drives serious chronic disorders. Malva parviflora L. (family Malvaceae) may represent a source for anti-inflammatory metabolites based on its potent anti-inflammatory activity. Its total ethanol extract demonstrated notable inhibition of cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX), with IC 50 values comparable to those of the reference drugs indomethacin and zileuton, respectively. The hexane fraction was the most active fraction (lowest IC₅₀) among the solvent partitions (dichloromethane, ethyl acetate, and butanol). Subsequent column chromatography of the hexane fraction produced two compounds: Cassipourol, isolated for the first time from the Malvaceae family, and β -sitosterol. Their structures were confirmed by matching their NMR and mass spectrometry data with literature. Both were validated in vitro as dual COX/LOX inhibitors, exhibiting IC₅₀ values comparable to those of the standards. To uncover additional mechanisms, a compound–target–inflammation network was constructed using network pharmacology approaches, revealing 178 shared targets. Among these, tumor necrosis factor (TNF- α ) and the antiapoptotic protein B-cell lymphoma 2 (BCL-2) emerged as central nodes linked to inflammatory pathways. Subsequent assays in human colon carcinoma (Caco-2) and lung adenocarcinoma (A549) cell lines showed that β -sitosterol suppressed TNF- α and BCL-2 by approximately 55%, whereas cassipourol displayed only modest inhibition (~20%). Molecular docking predicted moderate ( ca. –4.5) and strong (> –5) binding affinities of both compounds to key inflammatory targets. Collectively, these results suggest that β -sitosterol from M. parviflora is a promising multitarget lead for inflammatory disorders, including cancer, whereas cassipourol requires further structural optimization and mechanistic investigation to improve its unfavorable physicochemical properties.

Scientific ReportsVol. 16(1)
Good health and well-being
Openalex Percentile: Top 5%
Cholesterol and Lipid Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cassipourol and β-sitosterol from Malva parviflora L.: a mechanistic study of dual anti-inflammatory action against COX/LOX and TNF-α/BCL-2 — Rania A. El Gedaily, Shymaa I. A. Abdel-dayem, et al. · Scientific Reports (2026) | TGRS Research Map | TGRS